Lupin Ltd. (LUPIN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 641789, "name": "Lupin", "stock_name": "Lupin", "full_name": "Lupin Ltd.", "name_url": "stocks-analysis/lupin", "exchange": 1, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "2,185.90", "chg": 56.5, "chgp": "2.65%", "dir": 1, "prev_price": "2,129.40", "mcapval": "99,528.00 Cr", "mcap": "Large Cap", "scripcode": 500257, "symbol": "LUPIN", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE326A01037", "curr_date": "Feb 03", "curr_time": "", "bse_nse_vol": "13.29 lacs", "exc_status": "Active", "traded_date": "Feb 03, 2026", "traded_date_str": "2026 02 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-1&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "MS", "url": "https://www.marketsmojo.com/mojostocks#!#top10", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-1&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Lupin Ltd. Opens Strong with Significant Gap Up, Reflecting Positive Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-opens-strong-with-significant-gap-up-reflecting-positive-market-sentiment-3818536", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LupinLtd_gapup_3818536.png", "date": "2026-02-03 12:00:34", "description": "Lupin Ltd. commenced trading on 3 Feb 2026 with a significant gap up, opening 5.67% higher and touching a new 52-week high of ₹2,249.3. This strong start underscores positive market sentiment amid a broader sectoral uptrend in Pharmaceuticals & Biotechnology." }, { "title": "Lupin Ltd. Hits Intraday High with 3.05% Surge on 3 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-hits-intraday-high-with-305-surge-on-3-feb-2026-3818497", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LupinLtd_priceRelatedfactors_3818497.png", "date": "2026-02-03 11:51:11", "description": "Lupin Ltd. surged to a fresh 52-week high of Rs 2249.3 on 3 Feb 2026, marking a robust intraday performance with a gain of 5.67% from the previous close. The pharmaceutical giant’s stock demonstrated strong buying interest throughout the session, outperforming the broader Sensex and its sector peers." }, { "title": "Lupin Ltd. Hits New 52-Week High at Rs.2249.3 Marking Significant Milestone", "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-hits-new-52-week-high-at-rs22493-marking-significant-milestone-3818306", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LupinLtd_priceRelatedfactors_3818306.png", "date": "2026-02-03 10:39:43", "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.2249.3 today, underscoring a notable rally and positive momentum in its stock performance. This milestone reflects the company’s sustained strength amid a dynamic market environment." }, { "title": "Lupin Ltd Gains 0.65%: 4 Key Factors Shaping This Week’s Mixed Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-gains-065-4-key-factors-shaping-this-weeks-mixed-momentum-3813050", "imagepath": "", "date": "2026-01-31 16:05:52", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>26 Jan:</strong> Lupin upgraded to Strong Buy on robust financials and bullish technicals</p>\n <p><strong>27 Jan:</strong> Technical momentum shifts signal bullish outlook amid mixed indicators</p>\n <p><strong>29 Jan:</strong> Downgrade to Buy amid mixed technical signals and cautious outlook</p>\n <p><strong>30 Jan:</strong> Week closes at Rs.2,151.05 (+0.65%) with Sensex up 1.62%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,137.15</div></div>\n <div class=\"stat-item\"><div cl..." }, { "title": "When is the next results date for Lupin Ltd.?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-lupin-ltd-3810254", "imagepath": "", "date": "2026-01-29 23:16:19", "description": "The next results date for Lupin Ltd. is scheduled for 12 February 2026...." }, { "title": "Lupin Ltd. Downgraded to 'Buy' by MarketsMOJO Amid Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/lupin-ltd-downgraded-to-buy-by-marketsmojo-amid-mixed-technical-signals-3808865", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LupinLtd_mojoScore_3808865.png", "date": "2026-01-29 08:10:06", "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating adjusted from Strong Buy to Buy as of 28 January 2026. This change reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate robust fundamentals and attractive valuation metrics, evolving technical indicators have prompted a more cautious stance among analysts." }, { "title": "Lupin Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3808718", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LupinLtd_technicaldot_3808718.png", "date": "2026-01-29 08:01:43", "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in its share price, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a complex but cautiously optimistic outlook for investors." }, { "title": "Lupin Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-indicators-3804942", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LupinLtd_technicaldot_3804942.png", "date": "2026-01-27 08:01:51", "description": "Lupin Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a modest day decline of 1.29%, the stock’s technical indicators, including MACD, RSI, and moving averages, suggest strengthening price momentum that could underpin future gains amid broader market challenges." }, { "title": "Lupin Ltd. Upgraded to Strong Buy on Robust Financials and Bullish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/lupin-ltd-upgraded-to-strong-buy-on-robust-financials-and-bullish-technicals-3804443", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LupinLtd_mojoScore_3804443.png", "date": "2026-01-26 08:10:11", "description": "Lupin Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Buy to Strong Buy as of 23 January 2026. This upgrade reflects significant improvements across four key parameters: quality, valuation, financial trend, and technicals. The company’s strong financial performance, attractive valuation metrics, and bullish technical indicators have collectively driven this positive reassessment, positioning Lupin as a compelling investment opportunity amid a challenging market backdrop." } ], "total": 593, "sid": "641789", "stock_news_url": "https://www.marketsmojo.com/news/lupin-641789" }, "announcements": [ { "details": "Lupin Limited has informed the Exchange regarding Grant of 149578 Options.", "source": "NSE", "caption": "Lupin Limited - ESOP/ESOS/ESPS", "datetime": "05-Dec-2019" }, { "details": "Lupin Limited has informed the Exchange regarding a press release dated December 03, 2019, titled \"Lupin Foundation Wins Award for Excellence in Corporate Social Responsibility at India", "source": "NSE", "caption": "Lupin Limited - Press Release", "datetime": "03-Dec-2019" }, { "details": "Lupin Limited has informed the Exchange regarding allotment of 60495 Equity Shares under ESOP", "source": "NSE", "caption": "Lupin Limited - Allotment of ESOP/ESPS", "datetime": "28-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "12 Feb 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Lupin Ltd. has declared <strong>600%</strong> dividend, ex-date: 25 Jul 25", "dt": "2025-07-25", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Lupin Ltd. has announced <strong>2:10</strong> stock split, ex-date: 27 Aug 10", "dt": "2010-08-27", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Lupin Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 11 Aug 06", "dt": "2006-08-11", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

26 Jan: Lupin upgraded to Strong Buy on robust financials and bullish technicals

27 Jan: Technical momentum shifts signal bullish outlook amid mixed indicators

29 Jan: Downgrade to Buy amid mixed technical signals and cautious outlook

30 Jan: Week closes at Rs.2,151.05 (+0.65%) with Sensex up 1.62%

Week Open

Rs.2,137.15

Read full news article

When is the next results date for Lupin Ltd.?

2026-01-29 23:16:19

The next results date for Lupin Ltd. is scheduled for 12 February 2026....

Read full news article

Lupin Ltd. Downgraded to 'Buy' by MarketsMOJO Amid Mixed Technical Signals

2026-01-29 08:10:06

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating adjusted from Strong Buy to Buy as of 28 January 2026. This change reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate robust fundamentals and attractive valuation metrics, evolving technical indicators have prompted a more cautious stance among analysts.

Read full news article

Lupin Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-01-29 08:01:43

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in its share price, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a complex but cautiously optimistic outlook for investors.

Read full news article

Lupin Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators

2026-01-27 08:01:51

Lupin Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a modest day decline of 1.29%, the stock’s technical indicators, including MACD, RSI, and moving averages, suggest strengthening price momentum that could underpin future gains amid broader market challenges.

Read full news article

Lupin Ltd. Upgraded to Strong Buy on Robust Financials and Bullish Technicals

2026-01-26 08:10:11

Lupin Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Buy to Strong Buy as of 23 January 2026. This upgrade reflects significant improvements across four key parameters: quality, valuation, financial trend, and technicals. The company’s strong financial performance, attractive valuation metrics, and bullish technical indicators have collectively driven this positive reassessment, positioning Lupin as a compelling investment opportunity amid a challenging market backdrop.

Read full news article